{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:11:54Z","timestamp":1774714314192,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"vor","delay-in-days":486,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jiph.2014.11.006","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T17:30:28Z","timestamp":1423330228000},"page":"493-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-2235","authenticated-orcid":false,"given":"Jaffar A.","family":"Al-Tawfiq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramzi W.","family":"Banda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riyadh A.","family":"Daabil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Dawamneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (2)","key":"10.1016\/j.jiph.2014.11.006_bib0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CMR.00040-08","article-title":"Infectious complications associated with monoclonal antibodies and related small molecules","volume":"22","author":"Salvana","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.jiph.2014.11.006_bib0090","first-page":"719","article-title":"The unexpected evolution of a case of diffuse large B-cell non-Hodgkin lymphoma","volume":"52","author":"G\u0103man","year":"2011","journal-title":"Rom J Morphol Embryol"},{"issue":"November (Suppl. 2)","key":"10.1016\/j.jiph.2014.11.006_bib0095","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.3949\/ccjm.78.s2.05","article-title":"Multiple sclerosis, natalizumab, and PML: helping patients decide","volume":"78","author":"Rudick","year":"2011","journal-title":"Clevel Clin J Med"},{"issue":"December (12)","key":"10.1016\/j.jiph.2014.11.006_bib0100","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/ibd.22943","article-title":"Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience","volume":"18","author":"Kane","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"September (9)","key":"10.1016\/j.jiph.2014.11.006_bib0105","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"March\u2013April (4)","key":"10.1016\/j.jiph.2014.11.006_bib0110","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ibd.23011","article-title":"Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics","volume":"19","author":"Singh","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"March (3)","key":"10.1016\/j.jiph.2014.11.006_bib0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MIB.0b013e31827eea78","article-title":"Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center","volume":"19","author":"Sakuraba","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"March (Suppl. 11)","key":"10.1016\/j.jiph.2014.11.006_bib0120","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/art.38443","article-title":"A27: polyomavirus excretion in children with rheumatic diseases on immunosuppressive therapy","volume":"66","author":"Raman","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"May (20)","key":"10.1016\/j.jiph.2014.11.006_bib0125","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"issue":"October (7)","key":"10.1016\/j.jiph.2014.11.006_bib0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/cir507","article-title":"JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals","volume":"53","author":"Viscidi","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"September (11)","key":"10.1016\/j.jiph.2014.11.006_bib0135","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa0904267","article-title":"Asymptomatic reactivation of JC virus in patients treated with natalizumab","volume":"361","author":"Chen","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2014.11.006_bib0140","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008142","article-title":"Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma","volume":"2013","author":"Sikkema","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"November (4)","key":"10.1016\/j.jiph.2014.11.006_bib0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12185-008-0168-2","article-title":"Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature","volume":"88","author":"Yokoyama","year":"2008","journal-title":"Int J Hematol"},{"issue":"May (20)","key":"10.1016\/j.jiph.2014.11.006_bib0150","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"issue":"August (16)","key":"10.1016\/j.jiph.2014.11.006_bib0155","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/cncr.28712","article-title":"Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project","volume":"120","author":"Carson","year":"2014","journal-title":"Cancer"},{"issue":"April (1)","key":"10.1016\/j.jiph.2014.11.006_bib0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1148\/radiology.187.1.8451420","article-title":"Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation","volume":"187","author":"Whiteman","year":"1993","journal-title":"Radiology"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034115000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034115000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T06:57:23Z","timestamp":1537858643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034115000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1876034115000064"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2014.11.006","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2014.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}